Article Versions Notes

Calienni MN, Maza Vega D, Temprana CF, Izquierdo MC, Ybarra DE, Bernabeu E, Moretton M, Alvira FC, Chiappetta D, Alonso SdV, et al. The Topical Nanodelivery of Vismodegib Enhances Its Skin Penetration and Performance In Vitro While Reducing Its Toxicity In Vivo. Pharmaceutics. 2021; 13(2):186. https://doi.org/10.3390/pharmaceutics13020186

Calienni, Maria Natalia, Daniela Maza Vega, C. Facundo Temprana, María Cecilia Izquierdo, David E. Ybarra, Ezequiel Bernabeu, Marcela Moretton, Fernando C. Alvira, Diego Chiappetta, Silvia del Valle Alonso, and et al. 2021. "The Topical Nanodelivery of Vismodegib Enhances Its Skin Penetration and Performance In Vitro While Reducing Its Toxicity In Vivo" Pharmaceutics 13, no. 2: 186. https://doi.org/10.3390/pharmaceutics13020186

Calienni, M. N., Maza Vega, D., Temprana, C. F., Izquierdo, M. C., Ybarra, D. E., Bernabeu, E., Moretton, M., Alvira, F. C., Chiappetta, D., Alonso, S. d. V., Prieto, M. J., & Montanari, J. (2021). The Topical Nanodelivery of Vismodegib Enhances Its Skin Penetration and Performance In Vitro While Reducing Its Toxicity In Vivo. Pharmaceutics, 13(2), 186. https://doi.org/10.3390/pharmaceutics13020186